The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer

Abstract CINSARC, a multigene expression signature originally developed in sarcomas, was shown to have prognostic impact in various cancers. We tested the prognostic value for disease-free survival (DFS) of CINSARC in a series of 6035 early-stage invasive primary breast cancers. CINSARC had independ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anthony Goncalves, Pascal Finetti, Daniel Birnbaum, François Bertucci
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/ecafbdc5cfd6482fbd26fa13182d387e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!